Uppsala University
Describing himself as a molecular doctor, Lars Lannfelt developed an interest early on in discovering the mechanisms behind diseases.
Photograph: Mikael Wallerstedt
A new therapy that can slow the progression of Alzheimer's disease will soon be on the market - after 23 years of methodical collaboration between researchers and the pharmaceutical industry. It all began with a research discovery made and patented by Professor Lars Lannfelt.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
